GlassScriptPhysician profile
Zheming Yu
NPI 1003436304
$17,374.39
in general payments reported to CMS, 2019-2025
16 companies · $3,923 in 2025
The $3,923 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $260 · 2023: $111 · 2024: $13K · 2025: $3,923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Food and Beverage: $1,119 · Travel and Lodging: $910 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,000.00 |
| Food and Beverage | $1,118.81 |
| Travel and Lodging | $910.24 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,643.49 | 2024-2025 | Activa PC, Percept PC Brainsense |
| Boston Scientific Corporation | $5,015.50 | 2024-2025 | Vercise, General - Dbs |
| Abbott Laboratories | $2,500.00 | 2025 | Infinity |
| Merz Pharmaceuticals, LLC | $351.57 | 2024-2025 | Xeomin, Inbrija |
| Abbvie INC. | $162.08 | 2022-2025 | Botox |
| Acorda Therapeutics, INC | $141.49 | 2022 | |
| Amneal Pharmaceuticals LLC | $140.15 | 2024-2025 | Crexont |
| Mdd US Operations, LLC | $127.69 | 2022-2025 | |
| Kyowa Kirin, INC. | $91.38 | 2024 | Nourianz |
| Alexion Pharmaceuticals, INC. | $51.47 | 2023-2024 | Ultomiris |
| Livanova USA, INC. | $41.33 | 2022-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Argenx US, INC. | $23.59 | 2022 | |
| Emd Serono, INC. | $23.00 | 2022 | |
| Lundbeck LLC | $22.67 | 2023 | Vyepti |
| Astrazeneca Pharmaceuticals LP | $21.29 | 2025 | Wainua |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $17.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zheming Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.